The effect of large doses of medroxyprogesterone acetate (MPA) on urinary estrogen levels and serum levels of cortisol T4 LH and testosterone in patients with advanced cancer
Sadoff, L.; Lusk, W.
Obstetrics and Gynecology 43(2): 262-267
1974
ISSN/ISBN: 0029-7844 PMID: 4359078 Document Number: 80195
Document emailed within 1 workday
Related Documents
Telimaa, S.; Kauppila, A.; Rönnberg, L.; Suikkari, A.M.; Seppälä, M. 1989: Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high-dose medroxyprogesterone acetate American Journal of Obstetrics and Gynecology 161(4): 866-871Frick, J.; Bartsch, G.; Weiske, W.H. 1977: The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels Contraception 15(6): 649-668
Anttila, L.; Koskinen, P.; Erkkola, R.; Irjala, K.; Ruutiainen, K. 1994: Serum testosterone, androstenedione and luteinizing hormone levels after short-term medroxyprogesterone acetate treatment in women with polycystic ovarian disease Acta Obstetricia et Gynecologica Scandinavica 73(8): 634-636
Novak, E.; Hendrix, J.W.; Seckman, C.E.; Kaiser, D.G.; Stoll, R.G. 1980: Endogenous serum testosterone in males after different doses and routes of administration of medroxyprogesterone acetate Journal of Reproductive Medicine 25(4): 157-160
Bonomi, P.; Gale, M.; Von Roenn, J.; Anderson, K.; Johnson, P.; Wolter, J.; Economou, S. 1988: Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen Seminars in Oncology 15(2 Suppl 1: 26-33
Siriwongse, T.; Snidvongs, W.; Tantayaporn, P.; Leepipatpaiboon, S. 1982: Effect of depo-medroxyprogesterone acetate on serum progesterone levels when administered on various cycle days Contraception 26(5): 487-493
Pannuti, F.; Di Marco, A.R.; Martoni, A.; Fruet, F.; Strocchi, E.; Burroni, P.; Marraro, D. 1982: Medroxyprogesterone acetate (MAP) in high doses in the treatment of breast cancer in advanced stages Minerva Ginecologica 34(11): 977-979
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Morse, H.C.; Leach, D.R.; Rowley, M.J.; Heller, C.G. 1973: Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men Journal of Reproduction and Fertility 32(3): 365-378
Barnes, R.B.; Roy, S.; Lobo, R.A. 1985: Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women Obstetrics and Gynecology 66(2): 216-219
Guarnieri, A.; Tucci, E.; D'Aniello, C.; Carli, A.; Mariani, L.; De Stefano, A.; Nardi, P. 1984: Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(5): 320-323
Mathur, D.N.; Toriola, A.L.; Dada, O.A. 1986: Serum cortisol and testosterone levels in conditioned male distance runners and nonathletes after maximal exercise Journal of Sports Medicine and Physical Fitness 26(3): 245-250
Abraham, G.E.; Maroulis, G.B.; Buster, J.E.; Chang, R.J.; Marshall, J.R. 1976: Effect of dexamethasone on serum cortisol and androgen levels in hirsute patients Obstetrics and Gynecology 47(4): 395-402
Lali, P.; Chandra, L.; Gupta, R.P. 1996: Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: A preliminary study Contraception 53(6): 363-365
Iino, Y.; Yamazaki, K.; Ogawa, T.; Hirai, T.; Arai, T.; Ishikawa, H.; Endo, K.; Kawai, T.; Izuo, M.; Takikawa, H. 1983: Effect of medroxyprogesterone acetate (MAP) and vitamin C on DMBA induced rat mammary cancer in relation to estrogen receptor(ER) Gan no Rinsho. Japan Journal of Cancer Clinics 29(9): 949-954
Lang, J.H.; Zhu, L.; Sun, Z.J.; Chen, J. 2003: Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 80(1): 35-39
Rymgayłło-Katska, M. 1989: Studies of the effect of gentamicin on the kidneys of healthy young rats. I. Effect of gentamicin on serum urea and creatinine levels and urinary protein levels in experimental animals Pediatria Polska 64(7): 449-455
Marquis, L.; Jagavkar, C.K. 1977: Plasma Cortisol Levels in Patients Treated Extensively with Fluprednylidene-21 Acetate Topical Cream (decoderm) Indian Journal of Dermatology Venereology and Leprology 43(2): 76-80
Bednarek-Tupikowska, G.; Tupikowski, K.; Bidzińska, B.; Kuliczkowska, J.; Filus, A.; Milewicz, A. 2005: The effect of estrogen deficiency, estrogen and estro-progestagene therapy on total plasma homocysteine and serum lipid peroxide levels in postmenopausal women Ginekologia Polska 76(9): 687-692
Triantafillidis, J.K.; Merikas, E.; Govosdis, V.; Konstandellou, E.; Cheracakis, P.; Barbatzas, C.; Tzourmakliotis, D.; Peros, G. 2003: Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer Hepato-Gastroenterology 50(Suppl 2): Cclvi